• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CPI - DEL CARIBE ENDOTAK RELIANCE; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CPI - DEL CARIBE ENDOTAK RELIANCE; IMPLANTABLE LEAD Back to Search Results
Model Number 0692
Device Problems Low impedance (2285); Capturing Problem (2891); Device Contamination With Biological Material (2908); Device Dislodged or Dislocated (2923); Material Integrity Problem (2978)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/07/2018
Event Type  Injury  
Manufacturer Narrative
The explanted lead was not expected to be returned for analysis.As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Event Description
Boston scientific received information that at the device check one week post-implant, this right ventricular (rv) lead exhibited increased pacing threshold measurements and a decrease in pacing impedance measurements.An x-ray showed the lead had moved slightly.A revision procedure was planned to reposition the lead the following day.At the revision, the helix could not be fully retracted.During manipulation, the lead was released from the heart tissue and was removed from the patient.Visual inspection noted tissue caught in the helix; the tissue was removed as much as possible, but the helix still did not function properly, requiring 20 turns to extend when the lead was straight.Therefore, a new lead of the same model was implanted without complication.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, visual inspection of the lead was performed.Testing was completed to assess lead electrical performance and inner/outer insulation integrity.Measurements throughout these tests were within normal limits.Microscopic inspections of the terminal pin assembly, lead body, and electrode tip found no anomalies.Laboratory testing did not identify any lead characteristics that would have resulted in the clinical observation of dislodgement.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK RELIANCE
Type of Device
IMPLANTABLE LEAD
Manufacturer (Section D)
CPI - DEL CARIBE
guidant puerto rico b. v.
dorado PR
Manufacturer (Section G)
CPI - DEL CARIBE
guidant puerto rico b. v.
dorado PR
Manufacturer Contact
tim degroot
4100 hamline ave. n
st. paul, MN 
6515826168
MDR Report Key7618839
MDR Text Key111646326
Report Number2124215-2018-08766
Device Sequence Number1
Product Code NVY
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/12/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/20/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date03/10/2020
Device Model Number0692
Other Device ID NumberRELIANCE 4-FRONT
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/29/2018
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Manufacturer Received06/12/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/10/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
0692; 7741; D433
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age67 YR
-
-